Evaluation of Patients With Vena Cava Inferior Thrombosis
Clinical Course and Prognosis of Patients With Vena Cava Inferior Thrombosis
1 other identifier
observational
120
1 country
1
Brief Summary
The purpose of the study is to evaluate patients with inferior vena cava (IVC)thrombosis in terms of etiology, clinical course and prognosis during long-term follow-up. Patients with isolated lower extremity DVT, matched for age and gender, serve as controls.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2007
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2007
CompletedFirst Submitted
Initial submission to the registry
February 27, 2008
CompletedFirst Posted
Study publicly available on registry
March 7, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2014
CompletedApril 15, 2015
April 1, 2015
6.8 years
February 27, 2008
April 14, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Recurrent venous thromboembolism
6, 12, 24 and 60 months
Secondary Outcomes (2)
All-cause mortality
6, 12, 24 and 60 months
Post-thrombotic syndrome
24 and 60 months
Study Arms (2)
1
Patients with vena cava inferior thrombosis
2
Patients with isolated lower-extremity DVT matched for gender and age
Eligibility Criteria
patients with venous thrombosis involving the inferior cava inferior obtained from the Main-Isar-Thrombosis registry in which all patients seen for venous thromboembolism in our department are registered
You may qualify if:
- age 18-90 years
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Division of Vascular Medicine, Department of Internal Medicine, J.W.Goethe University Hospital Frankfurt
Frankfurt am Main, Hesse, D-60590, Germany
Biospecimen
Whole blood, serum
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Birgit Linnemann, MD
Division of Vascular Medicine, Department of Internal Medicine, J.W.Goethe University Hospital Frankfurt/Main, Germany
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D.
Study Record Dates
First Submitted
February 27, 2008
First Posted
March 7, 2008
Study Start
July 1, 2007
Primary Completion
April 1, 2014
Study Completion
August 1, 2014
Last Updated
April 15, 2015
Record last verified: 2015-04